Long-Term Outcome of Coil Occlusion in Patients With Patent Ductus Arteriosus

Takata, Hitoshi; Hatori, Takashi; Sugiyama, Hisashi; Kitano, Masataka; Yamamoto, Eiichi; Nakano, Takeshi; Nagashima, Mitsugi; Shikata, Fumiaki; Tomita, Hideshi; Yazaki, Satoshi; Shiraishi, Isao; Ishii, Eiichi

doi:10.1253/circj.cj-10-0453

Cited by 9 publications

(9 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our experience, the rate of complications was 5.8%, which is similar to that reported in previous studies (3% - 10%) ( 9 , 18 , 21 , 22 ). The major complication was embolization of the devices, which was seen in 11 (2.7%) patients, all of which were retrieved by snaring or surgically with no adverse clinical or hemodynamic effects.…”

Section: Discussionsupporting

confidence: 91%

“…The overall closure rates just after procedure, at two weeks, two months, and six months after the implant were 73.7%, 84%, 93.6%, and 98.7%. Although the immediate success rate was 73.7% and lower (99%, 92.5%) than those in previous reports ( 19 , 20 ), the final coil occlusion rate was 99.2%, which is in accordance with the recently reported 97.8% in coil implantation by Takata et al ( 18 ) and 99.7% in ADO implantation by Pass et al ( 9 ) Moreover, Bilkis et al ( 8 ) reported that the use of the ADO achieved a closure rate of 66% at 24 hours, 97% one month, and 99% 12 months after implantation.…”

Section: Discussionsupporting

confidence: 89%

“…The success rate of 97.2% in our trial as a large scale study is in accordance with the international figures. Takata et al ( 18 ) reported 96.0% successful coil implantation in 286 out of 298 patients. In another study, Sultan et al ( 19 ) reported that PDA was successfully implanted in 491 (98.2%) cases.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Follow-Up Results of Device Occlusion of Patent Ductus Arteriosus

et al. 2016

View full text Add to dashboard Cite

BackgroundTranscatheter patent ductus arteriosus (PDA) closure is an established procedure.ObjectivesThe aim of the study was to assess midterm follow up of the Nit-Occlud coil and the amplatzer ductal occluder (ADO) closure of PDA.Patients and MethodsIn this cohort study, we collected the longitudinal data of patients who underwent percutaneous closure using coil or ADO from November 2005 to November 2013. A total of 404 patients with PDA closure by devices were included during the study period. Coil occlusion was performed in 220 patients and 184 patients underwent catheterization using ADO. Follow-up evaluations were performed with echocardiography at two weeks, two months, six months, and during the study period (in average 4.8 ± 3.8 years).ResultsThe patients’ mean age was 24 months (range: 1 - 312). The catheterization was successful in 393 (97.2%) patients and unsuccessful in 11 (2.7%). Immediate complete occlusion was seen in 290 (73.7 %) patients. The occlusion rates at two weeks, two months, six months, and during the study period were 73.7%, 84%, 93.6%, 98.7%, and 99.5%, respectively. Complications occurred in 23 (5.8%) patients during or immediately after the catheterization, and device embolization with 2.7% was the most common complication. Most complications occurred in a patient with pulmonary hypertension who was less than one year old and was undergoing the first year of experience with devices.ConclusionsOur findings showed that transcatheter occlusion of the PDA is an effective and safe intervention by coil or Amplatzer with excellent early and one-year outcomes. Pulmonary hypertension, age of less than 12 months and experience of less than one year may increase the complications of device closure.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Follow-Up Results of Device Occlusion of Patent Ductus Arteriosus

et al. 2016

View full text Add to dashboard Cite

show abstract

“…K E Y W O R D S calcified patent ductus arteriosus, duct occluder, transcatheter closure 1 | INTRODUCTION With the development of new devices such as embolization coils and the Amplatzer Duct Occluder (ADO), transcatheter closure has become the preferred technique to manage patent ductus arteriosus (PDA) withhigh occlusion rates and few serious complications 1. In contemporary practice coil occlusion is preferred for the closure of small PDAs,[1][2][3][4] while the ADO is commonly used for closure of PDAs greater than 2 mm with a sufficient aortic ampulla 1,5. Calcified PDAs can be seen in adults and it has been generally accepted that closure of a calcified There have been reports of transcatheter closure of calcified PDAs using the Rashkind double umbrella device, 9,10 which however often results in significant residual shunts, requiring a second intervention.…”

mentioning

confidence: 99%

Transcatheter closure of calcified patent ductus arteriosus in older adult patients: Immediate and 12-month follow-up results

Zhang

Sun

et al. 2016

Congenital Heart Disease

View full text Add to dashboard Cite

show abstract

“…Transcatheter therapies for congenital heart diseases (CHD) and vascular anomalies such as patent ductus arteriosus, aortopulmonary collaterals, congenital, and acquired veno‐venous collaterals have been widely and successfully applied as first‐line management strategy . Multiples devices including nitinol based, self‐expanding occluders devices (Amplatzer vascular plug, Amplatzer duct occluders from St Jude, Lifetech, or more recently Occlutech), or coils are currently used .…”

Section: Introductionmentioning

confidence: 99%